Articles by Walter Armstrong - Pharmaceutical Executive

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Articles by Walter Armstrong

The Book on Daniel

Oct 1, 2009

Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?

Betting the Pharma

Aug 1, 2009

With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble. Here are 10 to place stakes on.

What's the Deal at Solvay?

Aug 1, 2009

The Belgian drugmaker is pursuing a sale, inking deals, issuing debt, and launching a power drug for Parkinson's—all at once.

French Revolution

Jul 1, 2009

Chris Viehbacher's first fast and furious six months at the top of Sanofi-Aventis have heads spinning...and rolling.

ASCO Roundup: Winners, Losers, and Also Rans

Jun 3, 2009

Due to pharma's voluntary moratorium on doling out totefuls of freebies and all the lattes you can swallow, thousands of docs, researchers, and reporters had only their sleep-deprived selves to carry from data dump to data dump at this week?s American Society of Clinical Oncology (ASCO) annual confab in Orlando, Florida.

Attack of the Monster Merger

Mar 1, 2009

Just when you thought it was safe to go back into M&A, the mega merger returns. What's right about Pfizer-Wyeth, and what's scary.

Brand of the Year: Crestor

Feb 1, 2009

For aiming to be a game-changer in cardiovascular disease, we recognize comeback kid Crestor as the year's No. 1. Plus three fine finalists.

Forecast 2009: Up in the Air

Jan 1, 2009

We know what you're thinking: new president, rotten economy, patent cliff. Do you feel Evel? Well, do you?

The New Deals

Dec 1, 2008

Everything you wanted to know about the year's most important deals—and what to watch for in the future

ADVERTISEMENT

Click here